机构：[1]Radiotherapy, The Fourth Hospital of Hebei Medical University - North Gate, Shijiazhuang, China河北医科大学第四医院[2]Radiation Oncology, Fourth Hospital of Hebei Medical University and Hebei Province Tumor Hospital, Shijiazhuang, China河北医科大学第四医院[3]Medical Oncology, The Fourth Hospital of Hebei Medical University - North Gate, Shijiazhuang, China河北医科大学第四医院[4]Radiation Oncology, The Fourth Hospital of Hebei Medical University - North Gate, Shijiazhuang, China河北医科大学第四医院
第一作者机构：[1]Radiotherapy, The Fourth Hospital of Hebei Medical University - North Gate, Shijiazhuang, China
推荐引用方式(GB/T 7714)：
Wang Y.,Yu W.,Shi J.,et al.EGFR-TKIs compared with radiotherapy for patients of stage IV lung adenocarcinoma with EGFR mutation[J].ANNALS OF ONCOLOGY.2021,32:S976-S976.doi:10.1016/j.annonc.2021.08.1838.
APA：
Wang, Y.,Yu, W.,Shi, J.,Qiu, M.,Jiang, N....&Jia, Z..(2021).EGFR-TKIs compared with radiotherapy for patients of stage IV lung adenocarcinoma with EGFR mutation.ANNALS OF ONCOLOGY,32,
MLA：
Wang, Y.,et al."EGFR-TKIs compared with radiotherapy for patients of stage IV lung adenocarcinoma with EGFR mutation".ANNALS OF ONCOLOGY 32.(2021):S976-S976
医学